journal
https://read.qxmd.com/read/38577557/primary-malignant-melanoma-of-the-genitourinary-tract-case-series-of-a-rare-form-of-primary-mucosal-melanoma
#1
Olanrewaju Olapeju, Jonathan Shakesprere, Carie Boykin, Patrick Bacaj, Mohamad Salkini, Joanna Kolodney
Primary malignant melanoma of the genitourinary tract is extremely rare. We present two such cases in elderly Caucasian females. An 81-year-old female with urinary retention and polypoid urinary bladder mass and a 72-year-old female with gross hematuria and urethral caruncle. After thorough evaluation, they were both eventually diagnosed with primary urogenital melanoma (SOX10 and MART1-positive in tumor cells). In both cases, the presence of melanoma- in - situ and absence of primary melanoma in other sites were consistent with primary urogenital melanoma...
February 2024: Melanoma Management
https://read.qxmd.com/read/38229953/organ-sparing-central-pelvic-compartment-resection-for-the-treatment-of-vulvo-vaginal-melanomas
#2
REVIEW
Mark McGowan, Brent O'Carrigan, Filipe Correia Martins, Krishnayan Haldar, Pubudu Pathiraja
Vulvo-vaginal melanomas are one of the rarest gynecological oncology diseases with a poor survival compared with other malignancies. The 5-year survival varies from 13% to 32.3%. Vulvo-vaginal melanomas involving the upper 2/3rds of the vagina are usually treated with total pelvic exenteration (TPE). TPE surgery carries a 50% risk of major complications and also morbidity associated with double stomas. Central pelvic compartment resection is a novel organ-sparing surgical approach entailing radical total laparoscopic hysterectomy, bilateral salpingo-oophrectomy, laparoscopic vaginectomy and vulvectomy to reduce morbidity compared with TPE...
September 2023: Melanoma Management
https://read.qxmd.com/read/38230203/disulfidptosis-related-classification-patterns-and-tumor-microenvironment-characterization-in-skin-cutaneous-melanoma
#3
JOURNAL ARTICLE
Li Yang, Zi-Jian Cao, Yuan Zhang, Jin-Ke Zhou, Jun Tian
AIM: To identify distinct disulfidptosis-molecular subtypes and develop a novel prognostic signature. METHODS/MATERIALS: We integrated into this study multiple SKCM transcriptomic datasets from the Cancer Genome Atlas database and Gene Expression Omnibus dataset. The consensus clustering algorithm was applied to categorize SKCM patients into different DRG subtypes. RESULTS: Three distinct DRG subtypes were identified, which were correlated to different clinical outcomes and signaling pathways...
June 2023: Melanoma Management
https://read.qxmd.com/read/38221928/incidence-of-braf-mutations-in-cutaneous-melanoma-histopathological-and-molecular-analysis-of-a%C3%A2-ukrainian-population
#4
JOURNAL ARTICLE
Oleksandr Dudin, Ozar Mintser, Nazarii Kobyliak, Dmytro Kaminskyi, Roman Shabalkov, Alina Matvieieva, Olga Sukhanova, Antonina Kalmykova, Denys Kozakov, Artem Mashukov, Oksana Sulaieva
AIM: This study aimed to investigate the incidence of BRAF mutation in cutaneous melanoma in the Ukrainian population with respect to clinical and histopathological data. MATERIALS & METHODS: This single-center retrospective cohort study enrolled 299 primary CM with known BRAF status assessed by RT-PCR. RESULTS: The overall BRAF mutation rate was 56.5% in CM and demonstrated a link with the younger age (p < 0.001), anatomical site (p < 0...
March 2023: Melanoma Management
https://read.qxmd.com/read/37378006/primary-esophageal-melanoma-a-case-report
#5
Pooja Patel, Colton Boudreau, Samuel Jessula, Madelaine Plourde
Primary esophageal melanoma remains a rare entity with less than 350 case reports noted in the current literature. This diagnosis is associated with a poor prognosis and early detection and management remains fundamental. In this report, we examine the case of an 80-year-old female who presented with a 1-year course of progressive dysphagia and weight loss. Investigations revealed a primary esophageal melanoma with no evidence of metastases. Pathology did not identify any targetable markers for systematic therapy and thus the patient successfully underwent a minimally invasive esophagectomy...
December 2022: Melanoma Management
https://read.qxmd.com/read/36147875/uveal-melanoma-patient-attitudes-towards-prognostic-testing-using-gene-expression-profiling
#6
JOURNAL ARTICLE
Basil K Williams, Jennifer J Siegel, Katherina M Alsina, Lauren Johnston, Amanda Sisco, Kyleigh LiPira, Sara M Selig, Peter G Hovland
Aim: This study explored uveal melanoma patient experiences and regret following molecular prognostic testing using a 15-gene expression profile (GEP) test. Materials & methods: A retrospective, cross-sectional survey study was conducted through an online questionnaire capturing patient-reported experiences with prognostic biopsy/molecular testing. Results: Of 177 respondents, 159 (90%) wanted prognostic information at diagnosis. Most 15-GEP-tested patients who shared their results (99%) reported gaining value from testing, as did patients tested with other methods...
September 2022: Melanoma Management
https://read.qxmd.com/read/35813184/successful-electrochemotherapy-treatment-of-a-large-bleeding-lymph-node-melanoma-metastasis
#7
Fredrik J Landström, Frida E Jakobsson, Stefan J Kristiansson
Despite the progress in immunotherapy and targeted therapy for patients with cutaneous malignant melanoma not all patients with loco-regional recurrences will respond to treatment. Electrochemotherapy is a relatively new treatment modality where the efficacy of a chemotherapeutic drug is enhanced by an electrical field. Here we report a case of a 68-year-old woman with a large therapy resistant inguinal lymph node melanoma metastasis complicated by bleeding that was successfully treated with electrochemotherapy...
June 2022: Melanoma Management
https://read.qxmd.com/read/35497071/improved-overall-survival-in-dual-compared-to-single-immune-checkpoint-inhibitors-in-braf-v600-negative-advanced-melanoma
#8
JOURNAL ARTICLE
Adi Kartolo, Cynthia Yeung, Markus Kuksis, Wilma Hopman, Tara Baetz
Aim: To evaluate the efficacy of dual versus single immune checkpoint inhibitors (ICI) in BRAF wild-type advanced melanoma patients. Materials & methods: A retrospective study of all advanced BRAF wild-type melanoma patients on palliative-intent ICI between 2015 and 2020 (n = 67). Results: Dual ICI had better overall survival (OS) when compared with single ICI in BRAF wild-type patients (hazard ratio: 0.204; 95% CI: 0.064-0.649; p = 0...
April 2022: Melanoma Management
https://read.qxmd.com/read/35295901/knowledge-and-behavior-of-lebanese-parents-regarding-melanoma-prevention-in-public-and-private-school-children
#9
JOURNAL ARTICLE
Léa El Haddad, Tarek Souaid, Diana Kadi, Joya-Rita Hindy, Karim Souaid, Hampig Raphael Kourie, Roland Tomb
Aim: Assess the knowledge and behavior of Lebanese parents when it comes to melanoma and its prevention in children. Methods: A survey, to be completed by parents, was sent through children from three schools. Results: During sun exposure only 23.5% of 1012 respondents were always covering enough areas of their children's skin and 74.1% did not always apply sunscreen to their children. Parents of private school children were three times more likely to apply sunscreen to their children when exposed to sun, four times more likely to reapply sunscreen every 2-3 h and 21 times more likely to use a higher sun protection factor...
December 2021: Melanoma Management
https://read.qxmd.com/read/34900220/pulmonary-metastatic-melanoma-current-state-of-diagnostic-imaging-and-treatments
#10
REVIEW
Kermit S Zhang, Tomer Pelleg, Sabrina Campbell, Catalina Rubio, Anthony Lukas Loschner, Susanti Ie
Melanoma is the deadliest form of skin cancer with an estimated incidence of over 160,000 cases annually and about 41,000 melanoma-related deaths per year worldwide. Malignant melanoma (MM) primarily occurs in the skin but has been described in other organs. Although the respiratory system is generally afflicted by tumors such as lung cancer, it is also rarely affected by primary MM. The estimated incidence of pulmonary MM of the lung accounts for 0.01% of all primary lung tumors. The current understanding of pulmonary MM of the lung pathophysiology and its management are not well established...
September 2021: Melanoma Management
https://read.qxmd.com/read/34900219/evolving-treatments-and-future-therapeutic-targets-in-desmoplastic-melanoma
#11
EDITORIAL
Matthew J Hadfield, Alla Turshudzhyan, Jane M Grant-Kels
No abstract text is available yet for this article.
September 2021: Melanoma Management
https://read.qxmd.com/read/34084450/impact-of-rurality-on-melanoma-diagnosis-in-utah
#12
JOURNAL ARTICLE
Tawnya L Bowles, Carol Sweeney, John Snyder, Jesse Gygi, Brad Bott, Daniel Wray, Timothy J Yeatman, William T Sause
AIM: To analyze trends in Utah melanoma diagnosis and study the impact of rurality. PATIENTS & METHODS: State-wide melanoma incidence was calculated using Surveillance, Epidemiology, and End Results data (2005-2013). A subset of 5199 patients treated in an integrated healthcare system was further stratified for urban or rural residence. RESULTS: Early-stage tumors accounted for most of the increase in melanoma incidence over time. Age-adjusted melanoma incidence rate was higher in rural counties (46...
March 4, 2021: Melanoma Management
https://read.qxmd.com/read/34084449/braf-mek-inhibitors-as-steroid-sparing-bridge-prior-to-checkpoint-blockade-therapy-in-symptomatic-intracranial-melanoma
#13
Karam Khaddour, Tanner M Johanns, George Ansstas
The introduction of immune checkpoint blockade (ICB) and BRAF-MEK inhibitors has substantially improved outcomes in patients with metastatic melanoma. However, several challenging factors may hinder the efficacy of ICB in patients with symptomatic intracranial metastatic melanoma who are immunosuppressed due to the use of steroids prior to the administration of ICB. This has resulted in the exclusion of patients treated with high dose steroid at baseline from the majority of ICB clinical trials. In addition, despite the high efficacy of BRAF-MEK inhibitors in BRAF -mutant intracranial metastatic melanoma, most tumors will eventually progress...
February 15, 2021: Melanoma Management
https://read.qxmd.com/read/33552470/metastatic-melanoma-causing-recurrent-intussusception-and-perforation-of-small-bowel-case-reports-and-literature-review
#14
Yusuf Yagmur, Mehmet Ali Açıkgöz
Aim: To present cases of recurred jejuno-jejunal intussusception and jejunal perforation due to melanoma. Materials & methods: Case 1: A 43-year-old male under treatment for malignant melanoma was presented with abdominal pain and distention. Ten centimeter intussuscepted jejunum was resected. Second exploration was done due to failure to pass gas and stool. The reintussusception was detected and resection of reintussuscepted jejunum was performed. Case 2: A 63-year-old male was presented with abdominal pain...
January 18, 2021: Melanoma Management
https://read.qxmd.com/read/33552468/increase-of-sentinel-lymph-node-melanoma-staging-in-the-netherlands-still-room-and-need-for-further-improvement
#15
JOURNAL ARTICLE
Harmanjit Singh, Anjelli Wignakumar, Georgina J Williams, Shima Jamshidi, Daniel P Butler, Simon H Wood, Navid Jallali, Jonathan A Dunne
No abstract text is available yet for this article.
December 14, 2020: Melanoma Management
https://read.qxmd.com/read/33552469/letter-in-reply-increase-of-sentinel-lymph-node-melanoma-staging-in-the-netherlands-still-room-and-need-for-further-improvement
#16
JOURNAL ARTICLE
Eric A Deckers, Marieke Wj Louwman, Schelto Kruijff, Harald J Hoekstra
No abstract text is available yet for this article.
November 23, 2020: Melanoma Management
https://read.qxmd.com/read/33318781/the-challenge-of-primary-gastric-melanoma-a-systematic-review
#17
REVIEW
Gregory S Mellotte, Diya Sabu, Mary O'Reilly, Ray McDermott, Anthony O'Connor, Barbara M Ryan
AIM: Primary gastric melanoma is a rare clinical presentation. The purpose of this review was to compare the 1-year survival in patients who underwent surgery with patients who did not receive treatment. PATIENTS & METHODS: A systematic search of databases for case reports and case series of primary gastric melanoma was conducted. RESULTS: The mean survival of patients was 22 months. One-year survival was 56.5% with surgery, rising to 66% with adjuvant therapy...
November 23, 2020: Melanoma Management
https://read.qxmd.com/read/33318782/prognostic-value-of-intratumoral-lymphocyte-to-monocyte-ratio-and-m0-macrophage-enrichment-in-tumor-immune-microenvironment-of-melanoma
#18
JOURNAL ARTICLE
Neil K Jairath, Mark W Farha, Ruple Jairath, Paul W Harms, Lam C Tsoi, Trilokraj Tejasvi
Skin cutaneous melanoma is characterized by significant heterogeneity in its molecular, genomic and immunologic features. Whole transcriptome RNA sequencing data from The Cancer Genome Atlas of skin cutaneous melanoma (n = 328) was utilized. CIBERSORT was used to identify immune cell type composition, on which unsupervised hierarchical clustering was performed. Analysis of overall survival was performed using Kaplan-Meier estimates and multivariate Cox regression analyses. Membership in the lymphocyte:monocytelow , monocytehi gh  and M0high cluster was an independently poor prognostic factor for survival (HR: 3...
November 2, 2020: Melanoma Management
https://read.qxmd.com/read/32922729/is-the-neutrophil-to-lymphocyte-ratio-a-useful-prognostic-indicator-in-melanoma-patients
#19
REVIEW
Joshua T Cohen, Thomas J Miner, Michael P Vezeridis
The neutrophil-to-lymphocyte ratio (NLR) is gaining traction as a biomarker with utility in a variety of malignancies including melanoma. Intact lymphocyte function is necessary for tumor surveillance and destruction, and neutrophils play a role in suppressing lymphocyte proliferation and in the induction of lymphocyte apoptosis. Early research in melanoma indicates that in high-risk localized melanoma, a high NLR is correlated with worse overall and disease-free survival. Similarly, in metastatic melanoma treated with both metastasectomy and immunotherapies, an elevated NLR is predictive of shortened overall survival and progression-free survival...
August 25, 2020: Melanoma Management
https://read.qxmd.com/read/32922727/pandemic-medicine-the-management-of-advanced-melanoma-during-covid-19
#20
EDITORIAL
James R Patrinely, Douglas B Johnson
No abstract text is available yet for this article.
July 31, 2020: Melanoma Management
journal
journal
49992
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.